bluebird bio Inc (NASDAQ:BLUE)

114.41
Delayed Data
As of Mar 27
 +2.73 / +2.44%
Today’s Change
17.40
Today|||52-Week Range
128.88
+24.74%
Year-to-Date

Today’s Trading

Previous close111.68
Today’s open112.02
Day’s range111.25 - 115.32
Volume381,619
Average volume (3 months)757,682
Market cap$3.7B
Dividend yield--
Data as of 03/27/2015

Growth & Valuation

Earnings growth (last year)+9.41%
Earnings growth (this year)-42.62%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales95.78
Price/Book7.53

Competitors

 Today’s
change
Today’s
% change
GEVASynageva BioPharma C...+6.02+6.50%
CTLTCatalent Inc0.000.00%
XONIntrexon Corp+3.63+9.22%
KITEKite Pharma Inc+2.03+3.52%
Data as of 03/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$25.4M
Annual profit (last year)-$48.7M
Net profit margin-191.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating Officer
Jeffrey T. Walsh
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account